Insulin resistance in acromegaly: Defects in both hepatic and extrahepatic insulin action

I. Hansen, E. Tsalikian, B. Beaufrere, J. Gerich, M. Haymond, R. Rizza

Research output: Contribution to journalArticle

180 Citations (Scopus)

Abstract

Short-term growth hormone excess is associated with impaired hepatic and extrahepatic responses to insulin in the absence of a change in insulin binding. To determine whether similar defects occur after chronic growth hormone excess, insulin dose-response curves for stimulation of glucose utilization and suppression of glucose production and monocyte and erythrocyte insulin binding were determined in five acromegalic patients and six healthy volunteers of comparable age, sex, and obesity. During infusion of insulin, glucose infusion rates required to maintain euglycemia were significantly lower (P < 0.02 all) in the acromegalic patients than in the control subjects. Suppression of glucose production was impaired in the acromegalic subjects at insulin concentrations in the physiological range but not at insulin concentrations in the supraphysiological range. In contrast stimulation of glucose utilization was decreased in the acromegalic subjects at both physiological and supraphysiological insulin concentrations. Neither monocyte nor erythrocyte insulin binding differed significantly in the acromegalic and control subjects. These data indicate that chronic growth hormone excess is associated with a defect in both hepatic and extrahepatic insulin action. The decrease in glucose utilization at supraphysiological insulin concentrations in the acromegalic subjects and the normal monocyte and erythrocyte insulin binding suggest a postbinding alteration in insulin action.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume250
Issue number3
StatePublished - 1986
Externally publishedYes

Fingerprint

Acromegaly
Insulin Resistance
Insulin
Defects
Liver
Glucose
Growth Hormone
Monocytes
Erythrocytes
Healthy Volunteers

ASJC Scopus subject areas

  • Physiology
  • Endocrinology
  • Biochemistry

Cite this

Insulin resistance in acromegaly : Defects in both hepatic and extrahepatic insulin action. / Hansen, I.; Tsalikian, E.; Beaufrere, B.; Gerich, J.; Haymond, M.; Rizza, R.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 250, No. 3, 1986.

Research output: Contribution to journalArticle

Hansen, I, Tsalikian, E, Beaufrere, B, Gerich, J, Haymond, M & Rizza, R 1986, 'Insulin resistance in acromegaly: Defects in both hepatic and extrahepatic insulin action', American Journal of Physiology - Endocrinology and Metabolism, vol. 250, no. 3.
Hansen, I. ; Tsalikian, E. ; Beaufrere, B. ; Gerich, J. ; Haymond, M. ; Rizza, R. / Insulin resistance in acromegaly : Defects in both hepatic and extrahepatic insulin action. In: American Journal of Physiology - Endocrinology and Metabolism. 1986 ; Vol. 250, No. 3.
@article{54ddf0dd862341be96af1c2b00d53c37,
title = "Insulin resistance in acromegaly: Defects in both hepatic and extrahepatic insulin action",
abstract = "Short-term growth hormone excess is associated with impaired hepatic and extrahepatic responses to insulin in the absence of a change in insulin binding. To determine whether similar defects occur after chronic growth hormone excess, insulin dose-response curves for stimulation of glucose utilization and suppression of glucose production and monocyte and erythrocyte insulin binding were determined in five acromegalic patients and six healthy volunteers of comparable age, sex, and obesity. During infusion of insulin, glucose infusion rates required to maintain euglycemia were significantly lower (P < 0.02 all) in the acromegalic patients than in the control subjects. Suppression of glucose production was impaired in the acromegalic subjects at insulin concentrations in the physiological range but not at insulin concentrations in the supraphysiological range. In contrast stimulation of glucose utilization was decreased in the acromegalic subjects at both physiological and supraphysiological insulin concentrations. Neither monocyte nor erythrocyte insulin binding differed significantly in the acromegalic and control subjects. These data indicate that chronic growth hormone excess is associated with a defect in both hepatic and extrahepatic insulin action. The decrease in glucose utilization at supraphysiological insulin concentrations in the acromegalic subjects and the normal monocyte and erythrocyte insulin binding suggest a postbinding alteration in insulin action.",
author = "I. Hansen and E. Tsalikian and B. Beaufrere and J. Gerich and M. Haymond and R. Rizza",
year = "1986",
language = "English (US)",
volume = "250",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Insulin resistance in acromegaly

T2 - Defects in both hepatic and extrahepatic insulin action

AU - Hansen, I.

AU - Tsalikian, E.

AU - Beaufrere, B.

AU - Gerich, J.

AU - Haymond, M.

AU - Rizza, R.

PY - 1986

Y1 - 1986

N2 - Short-term growth hormone excess is associated with impaired hepatic and extrahepatic responses to insulin in the absence of a change in insulin binding. To determine whether similar defects occur after chronic growth hormone excess, insulin dose-response curves for stimulation of glucose utilization and suppression of glucose production and monocyte and erythrocyte insulin binding were determined in five acromegalic patients and six healthy volunteers of comparable age, sex, and obesity. During infusion of insulin, glucose infusion rates required to maintain euglycemia were significantly lower (P < 0.02 all) in the acromegalic patients than in the control subjects. Suppression of glucose production was impaired in the acromegalic subjects at insulin concentrations in the physiological range but not at insulin concentrations in the supraphysiological range. In contrast stimulation of glucose utilization was decreased in the acromegalic subjects at both physiological and supraphysiological insulin concentrations. Neither monocyte nor erythrocyte insulin binding differed significantly in the acromegalic and control subjects. These data indicate that chronic growth hormone excess is associated with a defect in both hepatic and extrahepatic insulin action. The decrease in glucose utilization at supraphysiological insulin concentrations in the acromegalic subjects and the normal monocyte and erythrocyte insulin binding suggest a postbinding alteration in insulin action.

AB - Short-term growth hormone excess is associated with impaired hepatic and extrahepatic responses to insulin in the absence of a change in insulin binding. To determine whether similar defects occur after chronic growth hormone excess, insulin dose-response curves for stimulation of glucose utilization and suppression of glucose production and monocyte and erythrocyte insulin binding were determined in five acromegalic patients and six healthy volunteers of comparable age, sex, and obesity. During infusion of insulin, glucose infusion rates required to maintain euglycemia were significantly lower (P < 0.02 all) in the acromegalic patients than in the control subjects. Suppression of glucose production was impaired in the acromegalic subjects at insulin concentrations in the physiological range but not at insulin concentrations in the supraphysiological range. In contrast stimulation of glucose utilization was decreased in the acromegalic subjects at both physiological and supraphysiological insulin concentrations. Neither monocyte nor erythrocyte insulin binding differed significantly in the acromegalic and control subjects. These data indicate that chronic growth hormone excess is associated with a defect in both hepatic and extrahepatic insulin action. The decrease in glucose utilization at supraphysiological insulin concentrations in the acromegalic subjects and the normal monocyte and erythrocyte insulin binding suggest a postbinding alteration in insulin action.

UR - http://www.scopus.com/inward/record.url?scp=0022477133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022477133&partnerID=8YFLogxK

M3 - Article

C2 - 3513613

AN - SCOPUS:0022477133

VL - 250

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 3

ER -